col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


42 Results       Page 1

 [1] 
Springer-Verlag: The European Journal of Health Economics
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―18 From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands Iris Meulman, Ellen Uiters, Mariëlle Cloin, Jeroen Struijs, Johan Polder, Niek Stadhouders
2 [GO] 2024―Feb―29 Can redistribution of vaccine improve global welfare? Lessons from COVID-19 Gunjan Kumari, Oindrila Dey
3 [GO] 2023―Dec―26 Impact of Long COVID on productivity and informal caregiving Joseph Kwon, Ruairidh Milne, Clare Rayner, Román Rocha Lawrence, Jordan Mullard, Ghazala Mir, et al. (+3)
4 [GO] 2023―Oct―21 Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic Sebastian Himmler, Job van Exel, Werner Brouwer, Sebastian Neumann-Böhme, Iryna Sabat, Jonas Schreyögg, et al. (+3)
5 [GO] 2023―Jul―06 Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic Sebastian Himmler, Job van Exel, Werner Brouwer, Sebastian Neuman-Böhme, Iryna Sabat, Jonas Schreyögg, et al. (+3)
6 [GO] 2023―Jun―17 COVID-19 and income inequality in OECD countries: a methodological comment-a reply John Wildman
7 [GO] 2023―Feb―23 COVID-19 and EQ-5D-5L health state valuation Edward J. D. Webb, Paul Kind, David Meads, Adam Martin
8 [GO] 2023―Feb―20 Risk, time preferences, trustworthiness and COVID-19 preventive behavior: evidence from France Julien Bergeot, Florence Jusot
9 [GO] 2023―Feb―02 The trade-off between health system resiliency and efficiency: evidence from COVID-19 in European regions Alvaro Almeida
10 [GO] 2023―Jan―19 Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany Hoa Thi Nguyen, Claudia M. Denkinger, Stephan Brenner, Lisa Koeppel, Lucia Brugnara, Robin Burk, et al. (+4)
11 [GO] 2022―Aug―11 Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic Yi Wang, Nantasit Luangasanatip, Wirichada Pan-ngum, Wanrudee Isaranuwatchai, Juthamas Prawjaeng, Sompob Saralamba, et al. (+3)
12 [GO] 2022―Aug―02 Reducing the basic reproduction number of COVID-19: a model simulation focused on QALYs, hospitalisation, productivity costs and optimal (soft) lockdown Jose Robles-Zurita
13 [GO] 2022―Jul―24 Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands Paul Mark Mitchell, Rachael L. Morton, Mickaël Hiligsmann, Samantha Husbands, Joanna Coast
14 [GO] 2022―Apr―25 Vaccination or NPI? A conjoint analysis of German citizens' preferences in the context of the COVID-19 pandemic Jacques Bughin, Michele Cincera, Evelyn Kiepfer, Dorota Reykowska, Florian Philippi, Marcin Żyszkiewicz, et al. (+2)
15 [GO] 2022―Mar―19 The common interests of health protection and the economy: evidence from scenario calculations of COVID-19 containment policies Florian Dorn, Sahamoddin Khailaie, Marc Stoeckli, Sebastian C. Binder, Tanmay Mitra, Berit Lange, et al. (+6)
16 [GO] 2022―Mar―19 Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment Jonathan Sicsic, Serge Blondel, Sandra Chyderiotis, François Langot, Judith E. Mueller
17 [GO] 2022―Mar―09 Inequality, public health, and COVID-19: an analysis of the Spanish case by municipalities Ignacio Amate-Fortes, Almudena Guarnido-Rueda
18 [GO] 2022―Feb―16 Communities and testing for COVID-19 Steven Stillman, Mirco Tonin
19 [GO] 2022―Feb―09 Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics Axel C. Mühlbacher, Andrew Sadler, Yvonne Jordan
20 [GO] 2022―Jan―11 COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach Matthias Klumpp, Dominic Loske, Silvio Bicciato
21 [GO] 2021―Nov―19 Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme Danny Wende, Dagmar Hertle, Claudia Schulte, Pedro Ballesteros, Uwe Repschläger
22 [GO] 2021―Nov―11 The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes Eline Moens, Louis Lippens, Philippe Sterkens, Johannes Weytjens, Stijn Baert
23 [GO] 2021―Nov―09 Microeconomics of intertemporal choice in zero-space during Covid-19: a behavioral economics perspective Javier Cifuentes-Faura, Renaud Di Francesco
24 [GO] 2021―Nov―06 Work ethics, stay-at-home measures and COVID-19 diffusion Vincenzo Alfano
25 [GO] 2021―Oct―22 Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan Eyal Lahav, Shosh Shahrabani, Mosi Rosenboim, Yoshiro Tsutsui
26 [GO] 2021―Aug―21 The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study Paul Hanly, Michelle Ahern, Linda Sharp, Diana Ursul, Gerard Loughnane
27 [GO] 2021―Aug―04 Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy Gaetano Perone
28 [GO] 2021―Jul―25 Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis Amit Summan, Arindam Nandi
29 [GO] 2021―Jul―20 Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe? Sebastian Himmler, Job van Exel, Werner Brouwer
30 [GO] 2021―Jul―15 How the COVID-19 pandemic can distort risk adjustment of health plan payment Richard C. van Kleef, Mieke Reuser
31 [GO] 2021―Jul―13 COVID-19: not the time for health economists? A plea for more proactive health economic involvement J.-Matthias Graf von der Schulenburg
32 [GO] 2021―Jul―08 The impact of COVID-19 pandemic on insurance demand: the case of China Xianhang Qian
33 [GO] 2021―Jul―05 Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests Juan Del Llano, Jorge Mestre-Ferrandiz, Jaime Espin, Jordi Gol-Montserrat, Alicia del Llano, Carlos Bringas
34 [GO] 2021―May―06 Assessing the consequences of quarantines during a pandemic Rikard Forslid, Mathias Herzing
35 [GO] 2021―May―03 Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections Donatella Saccone
36 [GO] 2021―Mar―22 Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe Mounir Amdaoud, Giuseppe Arcuri, Nadine Levratto
37 [GO] 2021―Feb―18 COVID-19 and income inequality in OECD countries John Wildman
38 [GO] 2021―Jan―02 COVID-19 and the role of inequality in French regional departments Victor Ginsburgh, Glenn Magerman, Ilaria Natali
39 [GO] 2020―Nov―24 More room for telemedicine after COVID-19: lessons for primary care? Livio Garattini, Marco Badinella Martini, Michele Zanetti
40 [GO] 2020―Jun―26 Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 Sebastian Neumann-Böhme, Nirosha Elsem Varghese, Iryna Sabat, Pedro Pita Barros, Werner Brouwer, Job van Exel, et al. (+2)
41 [GO] 2020―Jun―04 Historical evidence for economic effects of COVID-19 Rahmiye Figen Ceylan, Burhan Ozkan, Esra Mulazimogullari
42 [GO] 2020―Jun―03 Modelling Covid-19 under uncertainty: what can we expect? Meimei Wang, Steffen Flessa
 [1] 

42 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.013 sec